Abstract |
Saporin, a type I ribosome-inactivating protein from soapwort plant, is a potent protein synthesis inhibitor. Catalytically, saporin is a characteristic N- glycosidase, and it depurinates a specific adenine residue from a universally conserved loop of the major ribosomal RNA (rRNA) of eukaryotic cells. It is well-known that saporin induces apoptosis through different pathways, including ribotoxic stress response, cell signal transduction, genomic DNA fragmentation and RNA abasic lyase ( RAlyase) activity, and NAD+ depletion by poly-(ADP)-ribose polymerase hyperactivation. Saporin's high enzymatic activity, high stability, and resistance to conjugation procedures make it a well-suited tool for immunotherapy approaches.In the present study, we focus on saporin-based targeted toxins that may be efficacious therapeutic agents for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Our discussed points suggest that saporin may be a strategic molecule for therapeutic knockout treatments and a powerful candidate for novel drugs in the struggle against coronavirus 2019 (COVID-19).
|
Authors | Idris Arslan, Hafize Akgul, Murat Kara |
Journal | SLAS discovery : advancing life sciences R & D
(SLAS Discov)
Vol. 26
Issue 3
Pg. 330-335
(03 2021)
ISSN: 2472-5560 [Electronic] United States |
PMID | 33155515
(Publication Type: Journal Article)
|
Chemical References |
- Antiviral Agents
- Immunotoxins
- NAD
- Poly(ADP-ribose) Polymerases
- Saporins
|
Topics |
- Antiviral Agents
(chemistry, pharmacology)
- Apoptosis
(drug effects)
- Humans
- Immunotoxins
(chemistry, pharmacology)
- NAD
(metabolism)
- Poly(ADP-ribose) Polymerases
(metabolism)
- Saporins
(chemistry, pharmacology)
- Signal Transduction
(drug effects)
- COVID-19 Drug Treatment
|